DWP14012 40mg placebo

DRUG2 trials

Sponsors

Daewoong Pharmaceutical Co. LTD.

Conditions

Erosive EsophagitisHelicobacter Pylori Infected PatientsHelicobacter Pylori Infected SubjectsHelicobacter Pylori Infection

Phase 3

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3)

CompletedNCT03736369

Daewoong Pharmaceutical Co. LTD.Erosive Esophagitis

Start: 2018-12-13End: 2019-08-07Updated: 2020-09-03

Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori

CompletedNCT06751121

Daewoong Pharmaceutical Co. LTD.Helicobacter Pylori Infected Patients, Helicobacter Pylori Infected Subjects, Helicobacter Pylori Infection

Start: 2024-02-06End: 2025-04-24Updated: 2025-12-08